Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Seagen Inc.    SGEN

SEAGEN INC.

(SGEN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about SEAGEN INC.
11/09SEAGEN : Highlights Immuno-Oncology Data from Broad Portfolio During SITC Virtua..
BU
11/05SEAGEN : Announces Multiple ADCETRIS® (Brentuximab Vedotin) Presentations at the..
BU
11/02SEAGEN : to Host Virtual R&D Day on November 16, 2020
BU
10/29SEATTLE GENETICS : 3Q Earnings Snapshot
AQ
10/29SEAGEN : Reports Third Quarter 2020 Financial Results
BU
10/29SEAGEN : Announces Closing of $1.0 Billion Stock Sale to Merck
AQ
10/28SEAGEN : Announces Closing of $1.0 Billion Stock Sale to Merck
BU
10/14SEAGEN : to Host Conference Call and Webcast Discussion of Third Quarter 2020 Fi..
AQ
10/13SEAGEN : to Host Conference Call and Webcast Discussion of Third Quarter 2020 Fi..
BU
10/12SEATTLE GENETICS : Astellas and Seagen Announce Positive Topline Results from Se..
PR
10/12SEATTLE GENETICS : Seagen and Astellas Announce Positive Topline Results from Se..
BU
10/09SEATTLE GENETICS : Announces Corporate Name Change to Seagen Inc.
AQ
10/08SEATTLE GENETICS : Announces Corporate Name Change to Seagen Inc.
BU
09/21SEATTLE GENETICS : and Genmab Present Data from Tisotumab Vedotin innovaTV 204 P..
BU
09/18SEATTLE GENETICS : and Astellas Announce PADCEV® (enfortumab vedotin-ejfv) Signi..
BU
More most relevant news
All news about SEAGEN INC.
11/16Didi Chuxing, BYD roll out customized vans for ride-hailing service
RE
11/09SEAGEN : Highlights Immuno-Oncology Data from Broad Portfolio During SITC Virtua..
BU
11/05SEAGEN : Announces Multiple ADCETRIS® (Brentuximab Vedotin) Presentations at the..
BU
11/02SEAGEN : to Host Virtual R&D Day on November 16, 2020
BU
10/30SEAGEN : Management's Discussion and Analysis of Financial Condition and Results..
AQ
10/29SEATTLE GENETICS : 3Q Earnings Snapshot
AQ
10/29SEAGEN INC. : Results of Operations and Financial Condition (form 8-K)
AQ
10/29SEAGEN : Reports Third Quarter 2020 Financial Results
BU
10/29SEAGEN : Announces Closing of $1.0 Billion Stock Sale to Merck
AQ
10/28SEAGEN : Announces Closing of $1.0 Billion Stock Sale to Merck
BU
More news
News in other languages on SEAGEN INC.
11/05US-Konzern Merck & Co übernimmt Krebsforscher Velosbio
10/26SEAGEN INC. : Veröffentlichung des Quartalsergebnisses
10/26SEAGEN INC. : publication des résultats trimestriels
10/1410 Biotechs qui font parler d'elles
09/14Aktien New York Schluss: Übernahmen bescheren starken Wochenauftakt
09/14Aktien New York: Übernahme-Welle sorgt für einen starken Wochenauftakt
09/14DPA-AFX-ÜBERBLICK : UNTERNEHMEN vom 14.09.2020 - 15.15 Uhr
09/14Aktien New York Ausblick: Übernahme-Welle heizt die Stimmung auf
09/14US-Konzern Merck & Co steigt für Krebsmittelforschung bei Seattle Genetics ei..
07/15GSK : un groupe d'experts vote pour le traitement du myélome
Press releases
11/09SEAGEN : Highlights Immuno-Oncology Data from Broad Portfolio During SITC Virtua..
BU
11/05SEAGEN : Announces Multiple ADCETRIS® (Brentuximab Vedotin) Presentations at the..
BU
11/02SEAGEN : to Host Virtual R&D Day on November 16, 2020
BU
10/30SEAGEN : Management's Discussion and Analysis of Financial Condition and Results..
AQ
10/29SEATTLE GENETICS : 3Q Earnings Snapshot
AQ
More press releases
Upcoming event on SEAGEN INC.